Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Sergio Giralt
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Disorders
Concepts & Ideas
Phenomena
Chemicals & Drugs
Sign-in to see full Profile
Network (preview)
91
Champlin, Richard
70
Champlin, Richard
61
De Lima, Marcos
61
Anderlini, Paolo
54
Khouri, Issa
43
Przepiorka, Donna
43
Hosing, Chitra
42
Saliba, Rima
41
Andersson, Borje
41
Couriel, Daniel
38
van Besien, Koen
34
Khouri, Issa
33
Ippoliti, Cindy
31
Gajewski, James
31
Mehra, RC
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Sergio Giralt (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Couriel Daniel R; Saliba Rima; de Lima Marcos; Giralt Sergio; Andersson Borje; Khouri Issa; Hosing Chitra; Ippoliti Cindy; Shpall Elizabeth J; Champlin Richard; Alousi Amin
A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(12):1555-62.
-
2009: Armistead Paul M; de Lima Marcos; Pierce Sherry; Qiao Wei; Wang Xuemei; Thall Peter F; Giralt Sergio; Ravandi Farhad; Kantarjian Hagop; Champlin Richard; Estey Elihu
Quantifying the survival benefit for allogeneic hematopoietic stem cell transplantation in relapsed acute myelogenous leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(11):1431-8.
-
2009: Ciurea Stefan O; de Lima Marcos; Cano Pedro; Korbling Martin; Giralt Sergio; Shpall Elizabeth J; Wang Xuemei; Thall Peter F; Champlin Richard E; Fernandez-Vina Marcelo
High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.
Transplantation 2009;88(8):1019-24.
-
2009: Qazilbash Muzaffar H; Amjad Ali Imran; Qureshi Suhail; Qureshi Sofia R; Saliba Rima M; Khan Ziad U; Hosing Chitra; Giralt Sergio A; De Lima Marcos J; Popat Uday R; Yusuf Syed W; Champlin Richard E
Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(10):1265-70.
-
2009: Parmar Simrit; Del Lima Marcos; Zou Yizhou; Patah Poliana A; Liu Ping; Cano Pedro; Rondon Gabriela; Pesoa Susana; de Padua Silva Leandro; Qazilbash Muzaffar H; Hosing Chitra; Popat Uday; Kebriaei Partow; Shpall Elizabeth J; Giralt Sergio; Champlin Richard E; Stastny Peter; Fernandez-Vina Marcelo
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease.
Blood 2009;114(14):2884-7.
-
2009: Ciurea Stefan O; Rodrigues Morgani; Giralt Sergio; de Lima Marcos
Aging, acute myelogenous leukemia, and allogeneic transplantation: do they belong in the same sentence?
Clinical lymphoma & myeloma 2009;9(4):289-97.
-
2009: Parikh Gaurav C; Amjad Ali Imran; Saliba Rima M; Kazmi Syed M A; Khan Ziad U; Lahoti Amit; Hosing Chitra; Mendoza Floralyn; Qureshi Suhail R; Weber Donna M; Wang Michael; Popat Uday; Alousi Amin M; Champlin Richard E; Giralt Sergio A; Qazilbash Muzaffar H
Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(7):812-6.
-
2009: Popat Uday; Saliba Rima; Thandi Rupinderjit; Hosing Chitra; Qazilbash Muzaffar; Anderlini Paolo; Shpall Elizabeth; McMannis John; Körbling Martin; Alousi Amin; Andersson Borje; Nieto Yago; Kebriaei Partow; Khouri Issa; de Lima Marcos; Weber Donna; Thomas Sheeba; Wang Michael; Jones Roy; Champlin Richard; Giralt Sergio
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):718-23.
-
2009: Hosing Chitra; Saliba Rima M; Ahlawat Sheena; Körbling Martin; Kebriaei Partow; Alousi Amin; De Lima Marcos; Okoroji Julia-Grace; McMannis John; Qazilbash Muzaffar; Anderlini Paolo; Giralt Sergio; Champlin Richard E; Khouri Issa; Popat Uday
Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma.
American journal of hematology 2009;84(6):335-7.
-
2009: De Padua Silva L; de Lima M; Kantarjian H; Faderl S; Kebriaei P; Giralt S; Davisson J; Garcia-Manero G; Champlin R; Issa J-P; Ravandi F
Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome.
Bone marrow transplantation 2009;43(11):839-43.
-
2009: Jabbour Elias; Giralt Sergio; Kantarjian Hagop; Garcia-Manero Guillermo; Jagasia Madan; Kebriaei Partow; de Padua Leandro; Shpall Elizabeth J; Champlin Richard; de Lima Marcos
Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia.
Cancer 2009;115(9):1899-905.
-
2009: Saliba R M; Komanduri K V; Giralt S; de Souza J; Patah P; Oran B; Couriel D; Rondon G; Champlin R E; de Lima M
Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML.
Bone marrow transplantation 2009;43(9):685-92.
-
2009: Giralt Sergio; Ballen Karen; Rizzo Douglas; Bacigalupo Andreas; Horowitz Mary; Pasquini Marcelo; Sandmaier Brenda
Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(3):367-9.
-
2009: Ramos Carlos A; Saliba Rima M; de Pádua Leandro; Khorshid Ola; Shpall Elizabeth J; Giralt Sergio; Patah Poliana A; Hosing Chitra M; Popat Uday R; Rondon Gabriela; Khouri Issa F; Nieto Yago L; Champlin Richard E; de Lima Marcos
Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
Haematologica 2009;94(2):249-57.
-
2009: Giralt Sergio
Allografting older patients--myths and realities.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(1 Suppl):146-8.
-
2009: Giralt Sergio; Bishop Michael R
Principles and overview of allogeneic hematopoietic stem cell transplantation.
Cancer treatment and research 2009;144():1-21.
-
2009: Giralt Sergio
Advances in stem cell transplantation: making it better and safer.
Clinical lymphoma & myeloma 2009;9 Suppl 3():S293-5.
-
2009: Champlin Richard; de Lima Marcos; Kebriaei Partow; Rondon Gabriela; Fisher Tobi; Jabbour Elias; Cortés Jorge E; Kantarjian Hagop; Anderlini Paolo; Alousi Amin; Hosing Chitra; Shpall Elizabeth; Popat Uday; Qazilbash Muzaffar; Andersson Borje; Giralt Sergio
Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era.
Clinical lymphoma & myeloma 2009;9 Suppl 3():S261-5.
-
2008: Qazilbash Muzaffar H; Saliba Rima M; Nieto Yago; Parikh Gaurav; Pelosini Matteo; Khan Fatima B; Jones Roy B; Hosing Chitra; Mendoza Floralyn; Weber Donna M; Wang Michael; Popat Uday; Alousi Amin; Anderlini Paolo; Champlin Richard E; Giralt Sergio
Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(12):1401-7.
-
2008: Wang Xin Shelley; Shi Qiuling; Williams Lori A; Cleeland Charles S; Mobley Gary M; Reuben James M; Lee Bang-Ning; Giralt Sergio A
Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation.
Cancer 2008;113(8):2102-9.
-
2008: Alousi Amin M; Saliba Rima M; Okoroji Grace-Julia; Macapinlac Homer A; Hosing Chitra; Korbling Martin; Samuels Barry I; Popat Uday; Kebriaei Partow; Anderlini Paolo; Qazilbash Muzaffar H; de Lima Marcos; Giralt Sergio A; Champlin Richard E; Khouri Issa F
Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation.
British journal of haematology 2008;142(5):786-92.
-
2008: Rondón Gabriela; Saliba Rima M; Khouri Issa; Giralt Sergio; Chan Kawah; Jabbour Elias; McMannis John; Champlin Richard; Shpall Elizabeth
Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(8):859-66.
-
2008: Andersson Borje S; de Lima Marcos; Thall Peter F; Wang Xuemei; Couriel Daniel; Korbling Martin; Roberson Soonja; Giralt Sergio; Pierre Betty; Russell James A; Shpall Elizabeth J; Jones Roy B; Champlin Richard E
Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(6):672-84.
-
2008: Khouri Issa F; McLaughlin Peter; Saliba Rima M; Hosing Chitra; Korbling Martin; Lee Ming S; Medeiros L Jeffrey; Fayad Luis; Samaniego Felipe; Alousi Amin; Anderlini Paolo; Couriel Daniel; de Lima Marcos; Giralt Sergio; Neelapu Sattva S; Ueno Naoto T; Samuels Barry I; Hagemeister Fredrick; Kwak Larry W; Champlin Richard E
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.
Blood 2008;111(12):5530-6.
-
2008: Hosing C; Saliba R M; Okoroji G-J; Popat U; Couriel D; Ali T; De Padua Silva L; Kebriaei P; Alousi A; De Lima M; Qazilbash M; Anderlini P; Giralt S; Champlin R E; Khouri I
High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(6):1166-71.
-
2008: Campagnaro Erica; Saliba Rima; Giralt Sergio; Roden Linda; Mendoza Floralyn; Aleman Ana; Cleeland Charles; Weber Donna; Brown Jane; Anderson Karen O
Symptom burden after autologous stem cell transplantation for multiple myeloma.
Cancer 2008;112(7):1617-24.
-
2008: de Lima M; Champlin R E; Thall P F; Wang X; Martin T G; Cook J D; McCormick G; Qazilbash M; Kebriaei P; Couriel D; Shpall E J; Khouri I; Anderlini P; Hosing C; Chan K W; Andersson B S; Patah P A; Caldera Z; Jabbour E; Giralt S
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(2):258-64.
-
2007: Sorror Mohamed L; Giralt Sergio; Sandmaier Brenda M; De Lima Marcos; Shahjahan Munir; Maloney David G; Deeg H Joachim; Appelbaum Frederick R; Storer Barry; Storb Rainer
Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.
Blood 2007;110(13):4606-13.
-
2007: Oran B; Giralt S; Couriel D; Hosing C; Shpall E J; de Meis E; Khouri I F; Qazilbash M; Anderlini P; Kebriaei P; Popat U; Carrasco-Yalan A; Champlin R E; de Lima M
Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(12):2540-4.
-
2007: Kebriaei Partow; Detry Michelle A; Giralt Sergio; Carrasco-Yalan Antonio; Anagnostopoulos Athanasios; Couriel Daniel; Khouri Issa F; Anderlini Paolo; Hosing Chitra; Alousi Amin; Champlin Richard E; de Lima Marcos
Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia.
Blood 2007;110(9):3456-62.
-
2007: Stadtmauer Edward A; Lonial Sagar; Vesole David H; Abonour Rafat; Alsina Melissa; Badros Ashraf; Comenzo Raymond; Durie Brian; Giralt Sergio; Hussein Mohamad; Jakubowiak Andrzej; Mehta Jayesh; Niesvizky Ruben; Orlowski Robert; Siegel David; Singhal Seema; Vescio Robert; Wang Michael; Zangari Maurizio; Munshi Nikhil C
A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings.
Clinical advances in hematology & oncology : H&O 2007;5(10 Suppl 15):7-19, quiz 21-2.
-
2007: Qazilbash Muzaffar H; Saliba Rima M; Ahmed Bilal; Parikh Gaurav; Mendoza Floralyn; Ashraf Noman; Hosing Chitra; Flosser Thuy; Weber Donna M; Wang Michael; Couriel Daniel R; Popat Uday; Kebriaei Partow; Alousi Amin M; Anderlini Paolo; Naeem Rizwan C; Champlin Richard E; Giralt Sergio A
Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(9):1066-72.
-
2007: Kontoyiannis Dimitrios P; Chamilos Georgios; Lewis Russell E; Giralt Sergio; Cortes Jorge; Raad Issam I; Manning John T; Han Xin
Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation.
Cancer 2007;110(6):1303-6.
-
2007: Jabbour E; Rondon G; Anderlini P; Giralt S A; Couriel D R; Champlin R E; Khouri I F
Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation.
Bone marrow transplantation 2007;40(5):431-5.
-
2007: Ostronoff Fabiana; Bueso-Ramos Carlos; Cortes Jorge; Giralt Sergio
Normal hematopoietic function and multiple bone marrow clonal abnormalities in a patient with acute myeloid leukemia after two mismatched stem-cell transplants with graft failure and autologous reconstitution.
American journal of hematology 2007;82(8):744-7.
-
2007: Jabbour Elias; Cortes Jorge; Kantarjian Hagop; Giralt Sergio; Andersson Borje S; Giles Francis; Shpall Elizabeth; Kebriaei Partow; Champlin Richard; de Lima Marcos
Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant-related toxicity.
Cancer 2007;110(2):340-4.
-
2007: Ozdemir E; Saliba R M; Champlin R E; Couriel D R; Giralt S A; de Lima M; Khouri I F; Hosing C; Kornblau S M; Anderlini P; Shpall E J; Qazilbash M H; Molldrem J J; Chemaly R F; Komanduri K V
Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies.
Bone marrow transplantation 2007;40(2):125-36.
-
2007: Gupta S; Jain A; Warneke C L; Gupta A; Shannon V R; Morice R C; Onn A; Jimenez C A; Bashoura L; Giralt S A; Dickey B F; Eapen G A
Outcome of alveolar hemorrhage in hematopoietic stem cell transplant recipients.
Bone marrow transplantation 2007;40(1):71-8.
-
2007: Wang M; Giralt S; Delasalle K; Handy B; Alexanian R
Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma.
Hematology (Amsterdam, Netherlands) 2007;12(3):235-9.
-
2007: Giralt Sergio A; Arora Mukta; Goldman John M; Lee Stephanie J; Maziarz Richard T; McCarthy Philip L; Sobocinski Kathleen A; Horowitz Mary M;
Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia.
British journal of haematology 2007;137(5):461-7.
-
2007: Anderson K O; Giralt S A; Mendoza T R; Brown J O; Neumann J L; Mobley G M; Wang X S; Cleeland C S
Symptom burden in patients undergoing autologous stem-cell transplantation.
Bone marrow transplantation 2007;39(12):759-66.
-
2007: Khouri Issa F; Saliba Rima M; Admirand Joan; O'Brien Susan; Lee Ming-S; Korbling Martin; Samuels Barry I; Giralt Sergio; Lima de Marcos; Keating Michael J; Champlin Richard E; Bueso-Ramos Carlos
Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia.
British journal of haematology 2007;137(4):355-63.
-
2007: Christoforidou Anna V; Saliba Rima M; Williams Patricia; Qazilbash Muzaffar; Roden Linda; Aleman Ana; Weber Donna; Mendoza Floralyn; Podoloff Donald; Wendt Richard; Breitz Hazel; Alexanian Raymond; Champlin Richard; Giralt Sergio
Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(5):543-9.
-
2007: Oran Betul; Donato Michele; Aleman Ana; Hosing Chitra; Korbling Martin; Detry Michelle A; Wei Caimiao; Anderlini Paolo; Popat Uday; Shpall Elizabeth; Giralt Sergio; Champlin Richard E
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(4):469-77.
-
2007: Oran Betul; Giralt Sergio; Saliba Rima; Hosing Chitra; Popat Uday; Khouri Issa; Couriel Daniel; Qazilbash Muzaffar; Anderlini Paolo; Kebriaei Partow; Ghosh Shubhra; Carrasco-Yalan Antonio; de Meis Ernesto; Anagnostopoulos Athanasios; Donato Michele; Champlin Richard E; de Lima Marcos
Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(4):454-62.
-
2007: Cata Juan P; Weng Han-Rong; Burton Allen W; Villareal Horatio; Giralt Sergio; Dougherty Patrick M
Quantitative sensory findings in patients with bortezomib-induced pain.
The journal of pain : official journal of the American Pain Society 2007;8(4):296-306.
-
2007: Saliba Rima M; de Lima Marcos; Giralt Sergio; Andersson Borje; Khouri Issa F; Hosing Chitra; Ghosh Shubhra; Neumann Joyce; Hsu Yvonne; De Jesus Jorge; Qazilbash Muzaffar H; Champlin Richard E; Couriel Daniel R
Hyperacute GVHD: risk factors, outcomes, and clinical implications.
Blood 2007;109(7):2751-8.
-
2007: Giralt Sergio
Allogeneic hematopoietic progenitor cell transplantation for the treatment of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors: lessons learned to date.
Clinical lymphoma & myeloma 2007;7 Suppl 3():S102-4.
-
2007: Giralt Sergio
Hematopoietic progenitor cell transplantation in 2007: new challenges and new opportunities for the center for international blood and marrow transplant research.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(3):263-4.
-
2007: Qazilbash M H; Saliba R M; Hosing C; Mendoza F; Qureshi S R; Weber D M; Wang M; Flosser T; Couriel D R; De Lima M; Kebriaei P; Popat U; Alousi A M; Champlin R E; Giralt S A
Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma.
Bone marrow transplantation 2007;39(5):279-83.
-
2007: Estey Elihu; de Lima Marcos; Tibes Raoul; Pierce Sherry; Kantarjian Hagop; Champlin Richard; Giralt Sergio
Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS).
Blood 2007;109(4):1395-400.
-
2006: Körbling Martin; Reuben James M; Gao Hui; Lee Bang-Ning; Harris David M; Cogdell David; Giralt Sergio A; Khouri Issa F; Saliba Rima M; Champlin Richard E; Zhang Wei; Estrov Zeev
Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis.
Transfusion 2006;46(10):1795-802.
-
2006: Johnson Malisha R; Del Carpio-Jayo Daniel; Lin Pei; Giralt Sergio; Anderlini Paolo; Champlin Richard E; Khouri Issa F; Vadhan-Raj Saroj; Medeiros L Jeffrey; Bueso-Ramos Carlos E
Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation.
Annals of diagnostic pathology 2006;10(5):263-8.
-
2006: Lekakis L; Giralt S; Couriel D; Shpall E J; Hosing C; Khouri I F; Anderlini P; Korbling M; Martin T; Champlin R E; de Lima M
Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies.
Bone marrow transplantation 2006;38(6):421-6.
-
2006: Lee H J; Oran B; Saliba R M; Couriel D M; Shin K; Massey P; Neumann J; de Lima M; Champlin R; Giralt S
Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy.
Bone marrow transplantation 2006;38(4):299-303.
-
2006: Kebriaei P; Saliba R M; Ma C; Ippoliti C; Couriel D R; de Lima M; Giralt S; Qazilbash M H; Gajewski J L; Ha C S; Champlin R E; Khouri I F
Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia.
Bone marrow transplantation 2006;38(3):203-9.
-
2006: Jabbour Elias; Cortes Jorge; Kantarjian Hagop M; Giralt Sergio; Jones Dan; Jones Roy; Giles Francis; Andersson Borje S; Champlin Richard; de Lima Marcos
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure.
Blood 2006;108(4):1421-3.
-
2006: Qazilbash Muzaffar H; Saliba Rima M; Aleman Ana; Lei X; Weber Donna; Carrasco Antonio; Champlin Richard E; Giralt Sergio A
Risk factors for relapse after complete remission with high-dose therapy for multiple myeloma.
Leukemia & lymphoma 2006;47(7):1360-4.
-
2006: Hosing Chitra; Saliba Rima M; Körbling Martin; Acholonu Sandra; McMannis John; Anderlini Paolo; Giralt Sergio; De Lima Marcos; Okoroji Grace-Julia; Couriel Daniel R; Champlin Richard; Khouri Issa F; Donato Michele L
High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 2006;47(7):1290-4.
-
2006: Hosing Chitra; Qazilbash Muzaffar H; Kebriaei Partow; Giralt Sergio; Davis Marilyn S; Popat Uday; Anderlini Paolo; Shpall Elizabeth J; McMannis John; Körbling Martin; Champlin Richard E
Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma.
British journal of haematology 2006;133(5):533-7.
-
2006: Ueno N T; Konoplev S; Buchholz T A; Smith T; Rondón G; Anderlini P; Giralt S A; Gajewski J L; Donato M L; Cristofanilli M; Champlin R E
High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy.
Bone marrow transplantation 2006;37(10):929-35.
-
2006: Giralt Sergio
The role of alemtuzumab in nonmyeloablative hematopoietic transplantation.
Seminars in oncology 2006;33(2 Suppl 5):S36-43.
-
2006: de Lima Marcos; Giralt Sergio
Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndrome.
Seminars in hematology 2006;43(2):107-17.
-
2006: Couriel Daniel R; Hosing Chitra; Saliba Rima; Shpall Elizabeth J; Anderlini Paolo; Rhodes Beverly; Smith Veronica; Khouri Issa; Giralt Sergio; de Lima Marcos; Hsu Yvonne; Ghosh Shubhra; Neumann Joyce; Andersson Borje; Qazilbash Muzzafar; Hymes Sharon; Kim Stella; Champlin Richard; Donato Michele
Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.
Blood 2006;107(8):3074-80.
-
2006: Qazilbash Muzaffar H; Saliba Rima; De Lima Marcos; Hosing Chitra; Couriel Daniel; Aleman Ana; Roden Linda; Champlin Richard; Giralt Sergio A
Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myeloma.
Cancer 2006;106(5):1084-9.
-
2006: Donato Michele L; Feasel Adrienne M; Weber Donna M; Prieto Victor G; Giralt Sergio A; Champlin Richard E; Duvic Madeleine
Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation.
Blood 2006;107(2):463-6.
-
2005: Cheng Yee Chung; Saliba Rima M; Rondón Gabriela; Giralt Sergio A; Lu Karen H; Bodurka Diane C; Gershenson David M; Champlin Richard E; Ueno Naoto T
Low prevalence of premature ovarian failure in women given reduced-intensity conditioning regimens for hematopoietic stem-cell transplantation.
Haematologica 2005;90(12):1725-6.
-
2005: Qazilbash Muzaffar H; Qu Zhenhong; Hosing Chitra; Couriel Daniel; Donato Michele; Giralt Sergio; Champlin Richard
Rituximab-induced acute liver failure after an allogeneic transplantation for chronic myeloid leukemia.
American journal of hematology 2005;80(1):43-5.
-
2005: Alamo J; Shahjahan M; Lazarus H M; de Lima M; Giralt S A
Comorbidity indices in hematopoietic stem cell transplantation: a new report card.
Bone marrow transplantation 2005;36(6):475-9.
-
2005: Couriel D R; Saliba R; Escalón M P; Hsu Y; Ghosh S; Ippoliti C; Hicks K; Donato M; Giralt S; Khouri I F; Hosing C; de Lima M J; Andersson B; Neumann J; Champlin R
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease.
British journal of haematology 2005;130(3):409-17.
-
2005: Kazama Toshiki; Ng Chaan S; Giralt Sergio A
Multiphasic CT and MRI appearances of extramedullary multiple myeloma involving the stomach, pancreas, and bladder.
Clinical imaging 2005;29(4):263-5.
-
2005: Hosing C; Saliba R M; Shahjahan M; Estey E H; Couriel D; Giralt S; Andersson B; Champlin R E; De Lima M
Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia.
Bone marrow transplantation 2005;36(2):157-62.
-
2005: Giralt Sergio
Bone marrow transplant in myelodysplastic syndromes: new technologies, same questions.
Current hematology reports 2005;4(3):200-7.
-
2005: Anderlini P; Saliba R; Acholonu S; Okoroji G-J; Donato M; Giralt S; Andersson B; Ueno N T; Khouri I; De Lima M; Hosing C; Cohen A; Ippoliti C; Romaguera J; Rodriguez M A; Pro B; Fayad L; Goy A; Younes A; Champlin R E
Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen.
Bone marrow transplantation 2005;35(10):943-51.
-
2005: Khouri Issa F; Saliba Rima M; Hosing Chitra; Okoroji Grace-Julia; Acholonu Sandra; Anderlini Paolo; Couriel Daniel; De Lima Marcos; Donato Michele L; Fayad Luis; Giralt Segio; Jones Roy; Korbling Martin; Maadani Farzaneh; Manning John T; Pro Barbara; Shpall Elizabeth; Younes Anas; McLaughlin Peter; Champlin Richard E
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2240-7.
-
2005: Wong Raymond; Shahjahan Munir; Wang Xuemei; Thall Peter F; De Lima Marcos; Khouri Issa; Gajewski James; Alamo Jorge; Couriel Daniel; Andersson Borje S; Donato Michelle; Hosing Chitra; Komanduri Krishna; Anderlini Paolo; Molldrem Jeffrey; Ueno Naoto T; Estey Elihu; Ippoliti Cindy; Champlin Richard; Giralt Sergio
Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(2):108-14.
-
2004: Anderlini Paolo; Sheth Sheetal; Hicks Krystal; Ippoliti Cindy; Giralt Sergio; Champlin Richard E
Re: Imatinib mesylate administration in the first 100 days after stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(12):883-4.
-
2004: Anderlini P; Acholonu S A; Okoroji G-J; Andersson B S; Couriel D R; De Lima M J; Donato M L; Khouri I F; Giralt S A; Ueno N T; Champlin R E
Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response.
Bone marrow transplantation 2004;34(6):511-4.
-
2004: Alexanian R; Weber D; Delasalle K; Handy B; Champlin R; Giralt S
Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma.
Bone marrow transplantation 2004;34(3):229-34.
-
2004: de Lima Marcos; Anagnostopoulos Athanasios; Munsell Mark; Shahjahan Munir; Ueno Naoto; Ippoliti Cindy; Andersson Borje S; Gajewski James; Couriel Daniel; Cortes Jorge; Donato Michele; Neumann Joyce; Champlin Richard; Giralt Sergio
Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation.
Blood 2004;104(3):865-72.
-
2004: de Lima Marcos; Couriel Daniel; Thall Peter F; Wang Xuemei; Madden Timothy; Jones Roy; Shpall Elizabeth J; Shahjahan Munir; Pierre Betty; Giralt Sergio; Korbling Martin; Russell James A; Champlin Richard E; Andersson Borje S
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.
Blood 2004;104(3):857-64.
-
2004: Couriel Daniel; Saliba Rima; Hicks Krystal; Ippoliti Cindy; de Lima Marcos; Hosing Chitra; Khouri Issa; Andersson Borje; Gajewski James; Donato Michele; Anderlini Paolo; Kontoyiannis Dimitrios P; Cohen Agueda; Martin Thomas; Giralt Sergio; Champlin Richard
Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.
Blood 2004;104(3):649-54.
-
2004: Caldera Humberto; Giralt Sergio
Stem cell transplantation for multiple myeloma: current status and future directions.
Current hematology reports 2004;3(4):249-56.
-
2004: Qazilbash Muzaffar H; Giralt Sergio A; Champlin Richard E
Nonmyeloablative stem cell transplantation for chronic myeloid leukemia.
Hematology/oncology clinics of North America 2004;18(3):703-13, xi.
-
2004: Anagnostopoulos Athanasios; Aleman Ana; Ayers Gregory; Donato Michele; Champlin Richard; Weber Donna; Alexanian Raymond; Giralt Sergio
Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma.
Cancer 2004;100(12):2607-12.
-
2004: Escalón Maricer P; Champlin Richard E; Saliba Rima M; Acholonu Sandra A; Hosing Chitra; Fayad Luis; Giralt Sergio; Ueno Naoto T; Maadani Farzaneh; Pro Barbara; Donato Michele; McLaughlin Peter; Khouri Issa F
Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2419-23.
-
2004: El-Zimaity Maha; Saliba Rima; Chan Kawah; Shahjahan Munir; Carrasco Antonio; Khorshid Ola; Caldera Humberto; Couriel Daniel; Giralt Sergio; Khouri Issa; Ippoliti Cindy; Champlin Richard; de Lima Marcos
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters.
Blood 2004;103(12):4674-80.
-
2004: Giralt Sergio
Bone marrow transplant in myelodysplastic syndromes: new technologies, same questions.
Current hematology reports 2004;3(3):165-72.
-
2004: Popat U; Hosing C; Saliba R M; Anderlini P; van Besien K; Przepiorka D; Khouri I F; Gajewski J; Claxton D; Giralt S; Rodriguez M; Romaguera J; Hagemeister F; Ha C; Cox J; Cabanillas F; Andersson B S; Champlin R E
Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.
Bone marrow transplantation 2004;33(10):1015-23.
-
2004: Mittal P; Saliba R M; Giralt S A; Shahjahan M; Cohen A I; Karandish S; Onida F; Beran M; Champlin R E; de Lima M
Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
Bone marrow transplantation 2004;33(10):1005-9.
-
2004: Donato Michele L; Aleman Ana; Champlin Richard E; Weber Donna; Alexanian Raymond; Ippoliti Cindy M; de Lima Marcos; Anagnostopoulos Athanasios; Giralt Sergio
High-dose topotecan, melphalan and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of multiple myeloma.
Leukemia & lymphoma 2004;45(4):755-9.
-
2004: Couriel Daniel R; Saliba Rima M; Giralt Sergio; Khouri Issa; Andersson Borje; de Lima Marcos; Hosing Chitra; Anderlini Paolo; Donato Michelle; Cleary Karen; Gajewski James; Neumann Joyce; Ippoliti Cindy; Rondon Gabriela; Cohen Agueda; Champlin Richard
Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(3):178-85.
-
2004: Anagnostopoulos A; Aleman A; Yang Y; Donato M; Weber D; Champlin R; Smith T; Alexanian R; Giralt S
Outcomes of autologous stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapy.
Bone marrow transplantation 2004;33(6):623-8.
-
2004: Anagnastopoulos Athanasios; Aleman Ana; Giralt Sergio
Nonmyeloablative reduced-intensity transplantation in multiple myeloma.
Seminars in oncology 2004;31(1):33-6.
-
2004: Khouri Issa F; Lee Ming-Sheng; Saliba Rima M; Andersson Borje; Anderlini Paolo; Couriel Daniel; Hosing Chitra; Giralt Sergio; Korbling Martin; McMannis John; Keating Michael J; Champlin Richard E
Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival.
Experimental hematology 2004;32(1):28-35.
-
2003: Khorshid O; de Meis E; Martin T; Jones R B; Shpall E J; Nieto Y; Khouri I; Shahjahan M; Gajewski J; Giralt S; Champlin R; de Lima M
Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplant.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(12):2538-40.
-
2003: Ueno Naoto T; Cheng Yee Chung; Rondón Gabriela; Tannir Nizar M; Gajewski James L; Couriel Daniel R; Hosing Chitra; de Lima Marcos J; Anderlini Paolo; Khouri Issa F; Booser Daniel J; Hortobagyi Gabriel N; Pagliaro Lance C; Jonasch Eric; Giralt Sergio A; Champlin Richard E
Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors.
Blood 2003;102(10):3829-36.
-
2003: Wong Raymond; Giralt Sergio A; Martin Thomas; Couriel Daniel R; Anagnostopoulos Athanasios; Hosing Chitra; Andersson Borje S; Cano Pedro; Shahjahan Munir; Ippoliti Cindy; Estey Elihu H; McMannis John; Gajewski James L; Champlin Richard E; de Lima Marcos
Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years.
Blood 2003;102(8):3052-9.
-
2003: Giralt Sergio; Bensinger William; Goodman Mark; Podoloff Donald; Eary Janet; Wendt Richard; Alexanian Raymond; Weber Donna; Maloney David; Holmberg Leona; Rajandran Joseph; Breitz Hazel; Ghalie Richard; Champlin Richard
166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials.
Blood 2003;102(7):2684-91.
-
2003: Trent Jonathan C; Charnsangavej Chusilp; Shah Hetal; Giralt Sergio; Ueno Naoto T
Hepatic haematoma after allogeneic transplantation.
British journal of haematology 2003;122(5):694.
-
2003: Ahmed Maha; Giles Francis; Joe Youngson; Weber Donna M; Jilani Iman; Manshouri Taghi; Giralt Sergio; De Lima Marcos; Keating Michael; Albitar Maher
Use of plasma DNA in detection of loss of heterozygosity in patients with multiple myeloma.
European journal of haematology 2003;71(3):174-8.
-
2003: Wong Raymond; Beguelin Guillermo Z; de Lima Marcos; Giralt Sergio A; Hosing Chitra; Ippoliti Cindy; Forman Arthur D; Kumar Ashok J; Champlin Richard; Couriel Daniel
Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation.
British journal of haematology 2003;122(1):128-34.
-
2003: Wong R; Rondon G; Saliba R M; Shannon V R; Giralt S A; Champlin R E; Ueno N T
Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer.
Bone marrow transplantation 2003;31(12):1157-63.
-
2003: Wong Raymond; de Lima Marcos; Couriel Daniel; Giralt Sergio; Hosing Chitra; Shahjahan Munir; Cheng Yee Chung; Bruton Jill; Champlin Richard; Khouri Issa
Treatment of relapsing refractory diffuse large cell lymphoma after matched unrelated donor bone marrow transplant with immunosuppression withdrawal and rituximab.
Leukemia & lymphoma 2003;44(5):829-32.
-
2003: Anagnostopoulos Athanasios; Aleman Ana; Giralt Sergio
Autologous and allogeneic stem cell transplantation in Waldenstrom's macroglobulinemia: review of the literature and future directions.
Seminars in oncology 2003;30(2):286-90.
-
2003: de Lima Marcos; Ravandi Farhad; Shahjahan Munir; Andersson Borje; Couriel Daniel; Donato Michele; Khouri Issa; Gajewski James; van Besien Koen; Champlin Richard; Giralt Sergio; Kantarjian Hagop
Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias.
Cancer 2003;97(5):1242-7.
-
2003: Champlin Richard; Khouri Issa; Anderlini Paolo; De Lima Marcos; Hosing Chitra; McMannis John; Molldrem Jeffrey; Ueno Naoto; Giralt Sergio
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications.
Oncology (Williston Park, N.Y.) 2003;17(1):94-100; discussion 103-7.
-
2002: De Lima Marcos; St John Lisa S; Wieder Eric D; Lee Ming S; McMannis John; Karandish Safa; Giralt Sergio; Beran Miroslav; Couriel Daniel; Korbling Martin; Bibawi Samer; Champlin Richard; Komanduri Krishna V
Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units.
British journal of haematology 2002;119(3):773-6.
-
2002: Couriel D R; Beguelin G Z; Giralt S; De Lima M; Hosing C; Kharfan-Dabaja M A; Anagnostopoulos A; Champlin R
Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.
Bone marrow transplantation 2002;30(8):543-6.
-
2002: Giralt S; Aleman A; Anagnostopoulos A; Weber D; Khouri I; Anderlini P; Molldrem J; Ueno N T; Donato M; Korbling M; Gajewski J; Alexanian R; Champlin R
Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma.
Bone marrow transplantation 2002;30(6):367-73.
-
2002: Kantarjian Hagop M; O'Brien Susan; Cortes Jorge E; Giralt Sergio A; Rios Mary Beth; Shan Jianqin; Giles Francis J; Thomas Deborah A; Faderl Stefan; De Lima Marcos; Garcia-Manero Guillermo; Champlin Richard; Arlinghaus Ralph; Talpaz Moshe
Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia.
Blood 2002;100(5):1590-5.
-
2002: Giralt S
Update on non-myeloablative stem cell transplantation for hematologic malignancies.
International journal of hematology 2002;76 Suppl 1():368-75.
-
2002: Giralt S
Update on non-myeloablative stem cell transplantation for hematologic malignancies.
International journal of hematology 2002;76 Suppl 1():176-83.
-
2002: Alexanian R; Weber D; Giralt S; Delasalle K
Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(7):1116-9.
-
2002: Anagnostopoulos A; Giralt S
Stem cell transplantation (SCT) for Waldenstrom's macroglobulinemia (WM).
Bone marrow transplantation 2002;29(12):943-7.
-
2002: Hosing C; Munsell M; Yazji S; Andersson B; Couriel D; de Lima M; Donato M; Gajewski J; Giralt S; Körbling M; Martin T; Ueno N T; Champlin R E; Khouri I F
Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(3):450-9.
-
2002: Wang Xin Shelley; Giralt Sergio A; Mendoza Tito R; Engstrom Martha C; Johnson Beth A; Peterson Neomi; Broemeling Lyle D; Cleeland Charles S
Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1319-28.
-
2002: Giralt Sergio; Anagnostopoulos Athanasios; Shahjahan Munir; Champlin Richard;
Nonablative stem cell transplantation for older patients with acute leukemias and myelodysplastic syndromes.
Seminars in hematology 2002;39(1):57-62.
-
2002: Gajewski James L; Rondon Gabriela; Donato Michele L; Anderlini Paolo; Korbling Martin; Ippoliti Cindy; Benyunes Mark; Miller Langdon L; LaTemple Denise; Jones Denny; Ashby Mark; Hellmann Sue; Durett April; Lauppe Jo; Geisler Deborah; Khouri Issa F; Giralt Sergio A; Andersson Borje; Ueno Naoto T; Champlin Richard
Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(10):550-6.
-
2002: Khouri Issa; Giralt Sergio; Champlin Richard
Non-myeloablative allogeneic hematopoietic transplantation and induction of graft-versus-malignancy.
Cancer treatment and research 2002;110():137-47.
-
2001: Khouri I F; Saliba R M; Giralt S A; Lee M S; Okoroji G J; Hagemeister F B; Korbling M; Younes A; Ippoliti C; Gajewski J L; McLaughlin P; Anderlini P; Donato M L; Cabanillas F F; Champlin R E
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality.
Blood 2001;98(13):3595-9.
-
2001: Gopal R; Ha C S; Tucker S L; Khouri I F; Giralt S A; Gajewski J L; Andersson B S; Cox J D; Champlin R E
Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity.
Cancer 2001;92(7):1949-58.
-
2001: Przepiorka D; Anderlini P; Saliba R; Cleary K; Mehra R; Khouri I; Huh Y O; Giralt S; Braunschweig I; van Besien K; Champlin R
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation.
Blood 2001;98(6):1695-700.
-
2001: Rodriguez J; Munsell M; Yazji S; Hagemeister F B; Younes A; Andersson B; Giralt S; Gajewski J; de Lima M; Couriel D; Romaguera J; Cabanillas F F; Champlin R E; Khouri I F
Impact of high-dose chemotherapy on peripheral T-cell lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(17):3766-70.
-
2001: Bibawi S; Abi-Said D; Fayad L; Anderlini P; Ueno N T; Mehra R; Khouri I; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Andreeff M; Andersson B S; Estey E H; Champlin R; Przepiorka D
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia.
American journal of hematology 2001;67(4):227-33.
-
2001: Ravandi F; Kantarjian H; Cohen A; Davis M; O'Brien S; Anderlini P; Andersson B; Claxton D; Donato M; Gajewski J; Khouri I; Korbling M; Ueno N; deVos D; Champlin R; Giralt S
Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study.
Bone marrow transplantation 2001;27(12):1221-5.
-
2001: Alexanian R; Weber D; Giralt S; Dimopoulos M; Delasalle K; Smith T; Champlin R
Impact of complete remission with intensive therapy in patients with responsive multiple myeloma.
Bone marrow transplantation 2001;27(10):1037-43.
-
2001: Anagnostopoulos A; Dimopoulos M A; Aleman A; Weber D; Alexanian R; Champlin R; Giralt S
High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia.
Bone marrow transplantation 2001;27(10):1027-9.
-
2001: Champlin R; Khouri I; Anderlini P; Gajewski J; Kornblau S; Molldrem J; Shimoni A; Ueno N; Giralt S
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation.
Bone marrow transplantation 2001;27 Suppl 2():S13-22.
-
2001: Konoplev S; Champlin R E; Giralt S; Ueno N T; Khouri I; Raad I; Rolston K; Jacobson K; Tarrand J; Luna M; Nguyen Q; Whimbey E
Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients.
Bone marrow transplantation 2001;27(8):877-81.
-
2001: Shimoni A; Smith T L; Aleman A; Weber D; Dimopoulos M; Anderlini P; Andersson B; Claxton D; Ueno N T; Khouri I; Donato M; Korbling M; Alexanian R; Champlin R; Giralt S
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma.
Bone marrow transplantation 2001;27(8):821-8.
-
2001: La Rosa A M; Champlin R E; Mirza N; Gajewski J; Giralt S; Rolston K V; Raad I; Jacobson K; Kontoyiannis D; Elting L; Whimbey E
Adenovirus infections in adult recipients of blood and marrow transplants.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(6):871-6.
-
2001: Giralt S; Thall P F; Khouri I; Wang X; Braunschweig I; Ippolitti C; Claxton D; Donato M; Bruton J; Cohen A; Davis M; Andersson B S; Anderlini P; Gajewski J; Kornblau S; Andreeff M; Przepiorka D; Ueno N T; Molldrem J; Champlin R
Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.
Blood 2001;97(3):631-7.
-
2001: Shimoni A; Gajewski J A; Donato M; Martin T; O'Brien S; Talpaz M; Cohen A; Korbling M; Champlin R; Giralt S
Long-Term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(10):568-75.
-
2001: Körbling M; Giralt S; Khouri I; Mirza N; Donato M; Anderlini P; Fischer H; Andreeff M; McMannis J; Champlin R
Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis.
Journal of clinical apheresis 2001;16(2):82-7.
-
2000: Salama M; Nevill T; Marcellus D; Parker P; Johnson M; Kirk A; Porter D; Giralt S; Levine J E; Drobyski W; Barrett A J; Horowitz M; Collins R H
Donor leukocyte infusions for multiple myeloma.
Bone marrow transplantation 2000;26(11):1179-84.
-
2000: Couriel D R; Hicks K; Giralt S; Champlin R E
Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation.
Current opinion in oncology 2000;12(6):582-7.
-
2000: Champlin R; Khouri I; Shimoni A; Gajewski J; Kornblau S; Molldrem J; Ueno N; Giralt S; Anderlini P
Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy.
British journal of haematology 2000;111(1):18-29.
-
2000: Kantarjian H M; Giles F J; O'Brien S; Giralt S; Talpaz M
Therapeutic choices in younger patients with chronic myelogenous leukemia.
Cancer 2000;89(8):1647-58.
-
2000: Anderlini P; Giralt S; Andersson B; Ueno N T; Khouri I; Acholonu S; Cohen A; Körbling M J; Manning J; Romaguera J; Sarris A; Rodriguez; Hagemeister F; Mclaughlin P; Cabanillas F; Champlin R E
Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease.
Bone marrow transplantation 2000;26(6):615-20.
-
2000: Collins R H; Goldstein S; Giralt S; Levine J; Porter D; Drobyski W; Barrett J; Johnson M; Kirk A; Horowitz M; Parker P
Donor leukocyte infusions in acute lymphocytic leukemia.
Bone marrow transplantation 2000;26(5):511-6.
-
2000: de Lima M; van Besien K; Gajewski J; Khouri I; Andersson B; Korbling M; Champlin R; Giralt S
High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant.
Bone marrow transplantation 2000;26(3):333-8.
-
2000: Donato M L; Gershenson D; Ippoliti C; Wharton J T; Bast R C; Aleman A; Anderlini P; Gajewski J G; Giralt S; Molldrem J; Ueno N; Lauppe J; Korbling M; Boyer J; Bodurka-Bevers D; Bevers M; Burke T; Freedman R; Levenback C; Wolf J; Champlin R E
High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer.
Bone marrow transplantation 2000;25(11):1137-40.
-
2000: Seong C M; Giralt S; Kantarjian H; Xu J; Swantkowski J; Hayes K; Glassman A B; Khouri I; Korbling M; Thall P; Siciliano M J; Champlin R E
Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(9):1831-6.
-
2000: Ghosh S; Champlin R E; Englund J; Giralt S A; Rolston K; Raad I; Jacobson K; Neumann J; Ippoliti C; Mallik S; Whimbey E
Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin.
Bone marrow transplantation 2000;25(7):751-5.
-
2000: Champlin R; van Besien K; Giralt S; Khouri I
Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens.
Current oncology reports 2000;2(2):182-91.
-
2000: Shimoni A; Giralt S; Khouri I; Champlin R
Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect.
Current oncology reports 2000;2(2):132-9.
-
2000: Porter D L; Collins R H; Hardy C; Kernan N A; Drobyski W R; Giralt S; Flowers M E; Casper J; Leahey A; Parker P; Mick R; Bate-Boyle B; King R; Antin J H
Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions.
Blood 2000;95(4):1214-21.
-
2000: Hortobagyi G N; Buzdar A U; Theriault R L; Valero V; Frye D; Booser D J; Holmes F A; Giralt S; Khouri I; Andersson B; Gajewski J L; Rondon G; Smith T L; Singletary S E; Ames F C; Sneige N; Strom E A; McNeese M D; Deisseroth A B; Champlin R E
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.
Journal of the National Cancer Institute 2000;92(3):225-33.
-
2000: Przepiorka D; Kernan N A; Ippoliti C; Papadopoulos E B; Giralt S; Khouri I; Lu J G; Gajewski J; Durett A; Cleary K; Champlin R; Andersson B S; Light S
Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease.
Blood 2000;95(1):83-9.
-
2000: Przepiorka D; Saliba R; Cleary K; Fischer H; Tonai R; Fritsche H; Khouri I F; Folloder J; Ueno N T; Mehra R; Ippoliti C; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Anderlini P; Andersson B S; Champlin R
Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(2A):190-7.
-
1999: Khouri I F; Lee M S; Romaguera J; Mirza N; Kantarjian H; Korbling M; Albitar M; Giralt S; Samuels B; Anderlini P; Rodriguez J; von Wolff B; Gajewski J; Cabanillas F; Champlin R
Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1293-9.
-
1999: Donato M L; Champlin R E; Van Besien K W; Korbling M; Cabanillas F; Anderlini P; Gajewski J G; Lauppe J; Durett A; Andersson B; Giralt S; Khouri I; Hagemeister F; Romaguera J E; Sarris A; McLaughlin P; Younes A; Ippoliti C; Blamble D A; Hester J; Gee A; Rodriguez M A
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma.
Leukemia & lymphoma 1999;35(3-4):317-24.
-
1999: Champlin R; Khouri I; Kornblau S; Marini F; Anderlini P; Ueno N T; Molldrem J; Giralt S
Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapy.
Hematology/oncology clinics of North America 1999;13(5):1041-57, vii-viii.
-
1999: Przepiorka D; Khouri I; Ippoliti C; Ueno N T; Mehra R; Körbling M; Giralt S; Gajewski J; Fischer H; Donato M; Cleary K; Claxton D; Chan K W; Braunschweig I; van Besien K; Andersson B S; Anderlini P; Champlin R
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation.
Bone marrow transplantation 1999;24(7):763-8.
-
1999: Przepiorka D; Smith T L; Folloder J; Khouri I; Ueno N T; Mehra R; Körbling M; Huh Y O; Giralt S; Gajewski J; Donato M; Cleary K; Claxton D; Braunschweig I; van Besien K; Andersson B S; Anderlini P; Champlin R
Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation.
Blood 1999;94(4):1465-70.
-
1999: O'Brien S; Kantarjian H; Koller C; Feldman E; Beran M; Andreeff M; Giralt S; Cheson B; Keating M; Freireich E; Rios M B; Talpaz M
Sequential homoharringtonine and interferon-alpha in the treatment of early chronic phase chronic myelogenous leukemia.
Blood 1999;93(12):4149-53.
-
1999: Przepiorka D; van Besien K; Khouri I; Hagemeister F; Samuels B; Folloder J; Ueno N T; Molldrem J; Mehra R; Körbling M; Giralt S; Gajewski J; Donato M; Cleary K; Claxton D; Braunschweig I; Andersson B; Anderlini P; Champlin R
Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(5):527-32.
-
1999: Przepiorka D; Khouri I; Thall P; Mehra R; Lee M S; Ippoliti C; Giralt S; Gajewski J; van Besien K; Andersson B; Körbling M; Deisseroth A B; Champlin R
Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia.
Bone marrow transplantation 1999;23(10):977-81.
-
1999: Champlin R; Khouri I; Komblau S; Molidrem J; Giralt S
Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect.
Oncology (Williston Park, N.Y.) 1999;13(5):621-8; discussion 631, 635-8, 641.
-
1999: Nguyen Q; Champlin R; Giralt S; Rolston K; Raad I; Jacobson K; Ippoliti C; Hecht D; Tarrand J; Luna M; Whimbey E
Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(3):618-23.
-
1999: Champlin R; Khouri I; Kornblau S; Molldrem J; Giralt S
Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancy.
Current opinion in oncology 1999;11(2):87-95.
-
1999: Kantarjian H M; O'Brien S; Smith T L; Rios M B; Cortes J; Beran M; Koller C; Giles F J; Andreeff M; Kornblau S; Giralt S; Keating M J; Talpaz M
Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):284-92.
-
1999: Giralt S; Khouri I; Champlin R
Non myeloablative "mini transplants".
Cancer treatment and research 1999;101():97-108.
-
1999: Champlin R; Khouri I; Giralt S
Graft-vs.-malignancy with allogeneic blood stem cell transplantation: a potential primary treatment modality.
Pediatric transplantation 1999;3 Suppl 1():52-8.
-
1999: Champlin R; Khouri I; Giralt S
Use of nonmyeloablative preparative regimens for allogeneic blood stem cell transplantation: induction of graft-vs.-malignancy as treatment for malignant diseases.
Journal of clinical apheresis 1999;14(1):45-9.
-
1998: Khouri I F; Romaguera J; Kantarjian H; Palmer J L; Pugh W C; Korbling M; Hagemeister F; Samuels B; Rodriguez A; Giralt S; Younes A; Przepiorka D; Claxton D; Cabanillas F; Champlin R
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(12):3803-9.
-
1998: Khouri I F; Keating M; Körbling M; Przepiorka D; Anderlini P; O'Brien S; Giralt S; Ippoliti C; von Wolff B; Gajewski J; Donato M; Claxton D; Ueno N; Andersson B; Gee A; Champlin R
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2817-24.
-
1998: Ueno N T; Rondón G; Mirza N Q; Geisler D K; Anderlini P; Giralt S A; Andersson B S; Claxton D F; Gajewski J L; Khouri I F; Körbling M; Mehra R C; Przepiorka D; Rahman Z; Samuels B I; van Besien K; Hortobagyi G N; Champlin R E
Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):986-93.
-
1998: Popat U; Przepiork D; Champlin R; Pugh W; Amin K; Mehra R; Rodriguez J; Giralt S; Romaguera J; Rodriguez A; Preti A; Andersson B; Khouri I; Claxton D; de Lima M; Donato M; Anderlini P; Gajewski J; Cabanillas F; van Besien K
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):63-9.
-
1998: Przepiorka D; Giralt S; Khouri I; Champlin R; Bueso-Ramos C
Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: review of forty cases.
American journal of hematology 1998;57(1):24-8.
-
1997: Ippoliti C; Champlin R; Bugazia N; Przepiorka D; Neumann J; Giralt S; Khouri I; Gajewski J
Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(11):3350-4.
-
1997: Kantarjian H M; O'Brien S M; Keating M; Beran M; Estey E; Giralt S; Kornblau S; Rios M B; de Vos D; Talpaz M
Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11(10):1617-20.
-
1997: Ippoliti C; Morgan A; Warkentin D; van Besien K; Mehra R; Khouri I; Giralt S; Gajewski J; Champlin R; Andersson B; Przepiorka D
Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir.
Bone marrow transplantation 1997;20(6):491-5.
-
1997: van Besien K; Thall P; Korbling M; Pugh W C; Khouri I; Mehra R; Giralt S; Anderlini P; Amin K; Mirza N; Seong D; Gajewski J; Hester J; Andersson B; Cabanillas F; Champlin R; Przepiorka D
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(3):150-6.
-
1997: Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan K W; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(2):76-82.
-
1997: Giralt S; Estey E; Albitar M; van Besien K; Rondón G; Anderlini P; O'Brien S; Khouri I; Gajewski J; Mehra R; Claxton D; Andersson B; Beran M; Przepiorka D; Koller C; Kornblau S; Kørbling M; Keating M; Kantarjian H; Champlin R
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.
Blood 1997;89(12):4531-6.
-
1997: Rondón G; Giralt S; Pereira M; Van Besien K; Mehra R; Champlin R; Andreeff M
Analysis of chimerism following allogeneic bone marrow transplantation by fluorescent-in-situ hybridization.
Leukemia & lymphoma 1997;25(5-6):463-7.
-
1997: van Besien K W; de Lima M; Giralt S A; Moore D F; Khouri I F; Rondón G; Mehra R; Andersson B S; Dyer C; Cleary K; Przepiorka D; Gajewski J L; Champlin R E
Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect.
Bone marrow transplantation 1997;19(10):977-82.
-
1997: Anderlini P; Przepiorka D; Lauppe J; Seong D; Giralt S; Champlin R; Körbling M
Collection of peripheral blood stem cells from normal donors 60 years of age or older.
British journal of haematology 1997;97(2):485-7.
-
1997: Khouri I F; Przepiorka D; van Besien K; O'Brien S; Palmer J L; Lerner S; Mehra R C; Vriesendorp H M; Andersson B S; Giralt S; Körbling M; Keating M J; Champlin R E
Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease.
British journal of haematology 1997;97(2):466-73.
-
1997: van Besien K; Verschraegen C; Mehra R; Giralt S; Kudelka A P; Edwards C L; Piamsonboom S; Termrungruanglert W; Champlin R; Kavanagh J J
Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue.
Gynecologic oncology 1997;65(2):366-9.
-
1997: Kantarjian H M; O'Brien S M; Estey E; Giralt S; Beran M; Rios M B; Keating M; de Vos D; Talpaz M
Decitabine studies in chronic and acute myelogenous leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11 Suppl 1():S35-6.
-
1997: Giralt S; Davis M; O'Brien S; van Besien K; Champlin R; de Vos D; Kantarjian H
Studies of decitabine with allogeneic progenitor cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11 Suppl 1():S32-4.
-
1997: Seong D; Giralt S; Fischer H; Hayes K; Glassman A; Arlinghaus R; Xu J; Kantarjian H; Siciliano M; Champlin R
Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia.
Bone marrow transplantation 1997;19(6):565-70.
-
1997: Przepiorka D; Anderlini P; Ippoliti C; Khouri I; Fietz T; Thall P; Mehra R; Giralt S; Gajewski J; Deisseroth A B; Cleary K; Champlin R; van Besien K; Andersson B; Körbling M
Allogeneic blood stem cell transplantation in advanced hematologic cancers.
Bone marrow transplantation 1997;19(5):455-60.
-
1997: Giralt S; Weber D; Colome M; Dimopoulos M; Mehra R; Van Besien K; Gajewski J; Andersson B; Khouri I; Przepiorka D; von Wolff B; Delasalle K; Korbling M; Seong D; Alexanian R; Champlin R
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):667-73.
-
1997: de Lima M; van Besien K W; Giralt S A; Khouri I F; Mehra R; Andersson B S; Przepiorka D; Gajewski J L; Korbling M; Champlin R E
Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
Bone marrow transplantation 1997;19(2):121-7.
-
1996: Przepiorka D; Ippoliti C; Khouri I; Anderlini P; Mehra R; Giralt S; Gajewski J; Fritsche H; Deisseroth A B; Cleary K; Champlin R; van Besien K; Andersson B; Korbling M
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus.
Transplantation 1996;62(12):1806-10.
-
1996: Körbling M; Anderlini P; Durett A; Maadani F; Bojko P; Seong D; Giralt S; Khouri I; Andersson B; Mehra R; vanBesien K; Mirza N; Przepiorka D; Champlin R
Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.
Bone marrow transplantation 1996;18(6):1073-9.
-
1996: Przepiorka D; Ippoliti C; Khouri I; Woo M; Mehra R; Le Bherz D; Giralt S; Gajewski J; Fischer H; Fritsche H; Deisseroth A B; Cleary K; Champlin R; Besien K; Andersson B; Maher R; Fitzsimmons W
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation.
Blood 1996;88(11):4383-9.
-
1996: van Besien K; Przepiorka D; Mehra R; Giralt S; Khouri I; Gajewski J; Andersson B; Champlin R
Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(11):3036-42.
-
1996: Rondón G; Giralt S; Huh Y; Khouri I; Andersson B; Andreeff M; Champlin R
Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia.
Bone marrow transplantation 1996;18(3):669-72.
-
1996: Khouri I F; Kantarjian H M; Talpaz M; Giralt S; Rios M O; Hester J P; Champlin R E; Deisseroth A B
Results with high-dose chemotherapy and unpurged autologous stem cell transplantation in 73 patients with chronic myelogenous leukemia: the MD Anderson experience.
Bone marrow transplantation 1996;17(5):775-9.
-
1996: Giralt S A; Kolb H J
Donor lymphocyte infusions.
Current opinion in oncology 1996;8(2):96-102.
-
1996: van Besien K W; Mehra R C; Giralt S A; Kantarjian H M; Pugh W C; Khouri I F; Moon Y; Williams P; Andersson B S; Przepiorka D; McCarthy P L; Gajewski J L; Deisseroth A B; Cabanillas F F; Champlin R
Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.
The American journal of medicine 1996;100(3):299-307.
-
1996: Giralt S A; van Besien K
Treatment of relapse after allogeneic bone marrow transplantation.
Cancer treatment and research 1996;84():279-90.
-
1996: van Besien K; Giralt S
Autologous bone marrow transplantation for leukemia and lymphoma.
Cancer treatment and research 1996;84():207-59.
-
1996: Champlin R; Giralt S; Gajewski J
T cells, graft-versus-host disease and graft-versus-leukemia: innovative approaches for blood and marrow transplantation.
Acta haematologica 1996;95(3-4):157-63.
-
1995: Giralt S; Hester J; Huh Y; Hirsch-Ginsberg C; Rondón G; Seong D; Lee M; Gajewski J; Van Besien K; Khouri I; Mehra R; Przepiorka D; Körbling M; Talpaz M; Kantarjian H; Fischer H; Deisseroth A; Champlin R
CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Blood 1995;86(11):4337-43.
-
1995: Giralt S; O'Brien S; Talpaz M; Van Besien K; Chan K W; Rondón G; Andersson B; Mehra R; Khouri I; Estey E
Interferon-alpha and interleukin-2 as treatment for leukemia relapse after allogeneic bone marrow transplantation.
Cytokines and molecular therapy 1995;1(2):115-22.
-
1995: Talpaz M; Kantarjian H; Liang J; Calvert L; Hamer J; Tibbits P; Durett A; Claxton D; Giralt S; Khouri I
Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cells.
Blood 1995;85(11):3257-63.
-
1995: van Besien K W; Khouri I F; Giralt S A; McCarthy P; Mehra R; Andersson B S; Przepiorka D; Gajewski J L; Bellare N; Nath R
Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1096-102.
-
1995: Przepiorka D; Nath R; Ippoliti C; Mehra R; Hagemeister F; Diener K; Dimopoulos M; Giralt S; Khouri I; Samuels B
A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for autologous transplantation for malignant lymphoma.
Leukemia & lymphoma 1995;17(5-6):427-33.
-
1995: Körbling M; Przepiorka D; Huh Y O; Engel H; van Besien K; Giralt S; Andersson B; Kleine H D; Seong D; Deisseroth A B
Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts.
Blood 1995;85(6):1659-65.
-
1995: Shaffer L; Giralt S; Champlin R; Chan K W
Treatment of leukemia relapse after bone marrow transplantation with interferon-alpha and interleukin 2.
Bone marrow transplantation 1995;15(2):317-9.
-
1994: Giralt S A; Champlin R E
Leukemia relapse after allogeneic bone marrow transplantation: a review.
Blood 1994;84(11):3603-12.
-
1994: Giralt S A; LeMaistre C F; Vriesendorp H M; Andersson B S; Dimopoulos M; Gajewski J; Van Besien K; Mehra R; Przepiorka D; Khouri I
Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(9):1923-30.
-
1994: Przepiorka D; Ippoliti C; Giralt S; van Beisen K; Mehra R; Deisseroth A B; Andersson B; Luna M; Cork A; Lee M
A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic marrow transplantation.
Bone marrow transplantation 1994;14(3):449-53.
-
1994: Giralt S; O'Brien S; Weeks E; Luna M; Kantarjian H
Leukemia cutis in acute promyelocytic leukemia: report of three cases after treatment with all-trans retinoic acid.
Leukemia & lymphoma 1994;14(5-6):453-6.
-
1994: Preti H A; O'Brien S; Giralt S; Beran M; Pierce S; Kantarjian H M
Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients.
The American journal of medicine 1994;97(1):60-5.
-
1994: Kantarjian H M; Talpaz M; Andersson B; Khouri I; Giralt S; Rios M B; Champlin R; Hester J; Deisseroth A B
High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia.
Bone marrow transplantation 1994;14(1):57-61.
-
1994: Khouri I F; Keating M J; Vriesendorp H M; Reading C L; Przepiorka D; Huh Y O; Andersson B S; van Besien K W; Mehra R C; Giralt S A
Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(4):748-58.
-
1994: Przepiorka D; Ippoliti C; Panina A; Goodrich J; Giralt S; van Besien K; Mehra R; Deisseroth A B; Andersson B; Luna M
Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation.
Bone marrow transplantation 1994;13(4):461-4.
-
1993: Anaissie E J; Kontoyiannis D P; Vartivarian S; Kantarjian H M; O'Brien S; Giralt S A; Andersson B S; Karl C; Champlin R E; Bodey G P
Effectiveness of an oral triazole for opportunistic mold infections in patients with cancer: experience with SCH 39304.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;17(6):1022-31.
-
1993: Dimopoulos M A; Alexanian R; Przepiorka D; Hester J; Andersson B; Giralt S; Mehra R; van Besien K; Delasalle K B; Reading C
Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma.
Blood 1993;82(8):2324-8.
-
1993: Giralt S; Escudier S; Kantarjian H; Deisseroth A; Freireich E J; Andersson B S; O'Brien S; Andreeff M; Fisher H; Cork A
Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation.
The New England journal of medicine 1993;329(11):757-61.
-
1993: Ippoliti C; Przepiorka D; Smith T; Maiese S; Giralt S; Andersson B S; Deisseroth A B; Champlin R E
Adverse effects of molgramostim in marrow transplant recipients.
Clinical pharmacy 1993;12(7):520-5.
-
1993: Giralt S A; Kantarjian H M; Talpaz M; Rios M B; Del Giglio A; Andersson B S; Przepiorka D; Deisseroth A B; Champlin R E
Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(6):1055-61.
-
1993: Ippoliti C; Przepiorka D; Giralt S; Andersson B S; Wallerstein R O; Gutterman J; Deisseroth A B; Champlin R E
Low-dose non-glycosylated rhGM-CSF is effective for the treatment of delayed hematopoietic recovery after autologous marrow or peripheral blood stem cell transplantation.
Bone marrow transplantation 1993;11(1):55-9.
-
1993: Guo J Q; Hirsch-Ginsberg C F; Xian Y M; Stass S A; Champlin R E; Giralt S A; McCredie K B; Campbell M L; Arlinghaus R B
Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
Hematologic pathology 1993;7(2):91-106.
-
1992: Przepiorka D; Giralt S; Huh Y O; Andreeff M; Luna M; Reading C; Thomas M; Champlin R E
T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphoma.
Transplantation proceedings 1992;24(6):2906-7.
Sign-in to see more
